S&P 500   5,253.05 (+0.09%)
DOW   39,778.57 (+0.05%)
QQQ   444.26 (-0.13%)
AAPL   171.75 (-0.90%)
MSFT   420.59 (-0.20%)
META   487.76 (-1.24%)
GOOGL   150.99 (+0.08%)
AMZN   180.23 (+0.22%)
TSLA   176.83 (-1.67%)
NVDA   904.20 (+0.19%)
NIO   4.52 (-3.21%)
AMD   180.34 (+0.42%)
BABA   72.47 (+1.23%)
T   17.65 (+0.57%)
F   13.22 (+1.23%)
MU   117.82 (-1.11%)
CGC   8.60 (-9.95%)
GE   175.08 (-2.80%)
DIS   122.45 (+1.22%)
AMC   3.67 (-15.44%)
PFE   27.93 (+0.54%)
PYPL   67.09 (+0.78%)
XOM   116.14 (+1.02%)
S&P 500   5,253.05 (+0.09%)
DOW   39,778.57 (+0.05%)
QQQ   444.26 (-0.13%)
AAPL   171.75 (-0.90%)
MSFT   420.59 (-0.20%)
META   487.76 (-1.24%)
GOOGL   150.99 (+0.08%)
AMZN   180.23 (+0.22%)
TSLA   176.83 (-1.67%)
NVDA   904.20 (+0.19%)
NIO   4.52 (-3.21%)
AMD   180.34 (+0.42%)
BABA   72.47 (+1.23%)
T   17.65 (+0.57%)
F   13.22 (+1.23%)
MU   117.82 (-1.11%)
CGC   8.60 (-9.95%)
GE   175.08 (-2.80%)
DIS   122.45 (+1.22%)
AMC   3.67 (-15.44%)
PFE   27.93 (+0.54%)
PYPL   67.09 (+0.78%)
XOM   116.14 (+1.02%)
S&P 500   5,253.05 (+0.09%)
DOW   39,778.57 (+0.05%)
QQQ   444.26 (-0.13%)
AAPL   171.75 (-0.90%)
MSFT   420.59 (-0.20%)
META   487.76 (-1.24%)
GOOGL   150.99 (+0.08%)
AMZN   180.23 (+0.22%)
TSLA   176.83 (-1.67%)
NVDA   904.20 (+0.19%)
NIO   4.52 (-3.21%)
AMD   180.34 (+0.42%)
BABA   72.47 (+1.23%)
T   17.65 (+0.57%)
F   13.22 (+1.23%)
MU   117.82 (-1.11%)
CGC   8.60 (-9.95%)
GE   175.08 (-2.80%)
DIS   122.45 (+1.22%)
AMC   3.67 (-15.44%)
PFE   27.93 (+0.54%)
PYPL   67.09 (+0.78%)
XOM   116.14 (+1.02%)
S&P 500   5,253.05 (+0.09%)
DOW   39,778.57 (+0.05%)
QQQ   444.26 (-0.13%)
AAPL   171.75 (-0.90%)
MSFT   420.59 (-0.20%)
META   487.76 (-1.24%)
GOOGL   150.99 (+0.08%)
AMZN   180.23 (+0.22%)
TSLA   176.83 (-1.67%)
NVDA   904.20 (+0.19%)
NIO   4.52 (-3.21%)
AMD   180.34 (+0.42%)
BABA   72.47 (+1.23%)
T   17.65 (+0.57%)
F   13.22 (+1.23%)
MU   117.82 (-1.11%)
CGC   8.60 (-9.95%)
GE   175.08 (-2.80%)
DIS   122.45 (+1.22%)
AMC   3.67 (-15.44%)
PFE   27.93 (+0.54%)
PYPL   67.09 (+0.78%)
XOM   116.14 (+1.02%)
NYSE:TBI

TrueBlue (TBI) Stock Price, News & Analysis

$12.61
+0.15 (+1.20%)
(As of 02:26 PM ET)
Today's Range
$12.47
$12.66
50-Day Range
$11.04
$14.56
52-Week Range
$10.15
$19.06
Volume
99,457 shs
Average Volume
454,344 shs
Market Capitalization
$395.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.00

TrueBlue MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
50.8% Upside
$19.00 Price Target
Short Interest
Healthy
5.50% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.62mentions of TrueBlue in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.51) to $1.11 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.19 out of 5 stars

Business Services Sector

116th out of 311 stocks

Help Supply Services Industry

12th out of 15 stocks

TBI stock logo

About TrueBlue Stock (NYSE:TBI)

TrueBlue, Inc., together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries. The PeopleManagement segment offers contingent, on-site industrial staffing, and commercial driver services, which includes on-site management and recruitment for the contingent industrial workforce of manufacturing, warehousing, and distribution facilities; and recruitment and management of contingent and dedicated commercial drivers to the transportation and distribution industries under the Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands. The company PeopleScout segment provides recruitment process outsourcing, talent advisory services, and managed service provider solutions including sourcing, screening, hiring, and onboarding services; operates Affinix, a technology platform for sourcing, screening, and delivering a permanent workforce to its clients; talent advisory services, such as employer branding, recruitment marketing, talent insights, diversity, equity and inclusion consulting, candidate assessment, and talent acquisition strategy consulting services; and contingent labor programs including vendor selection, performance management, compliance monitoring, and risk management. TrueBlue, Inc. was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. The company was incorporated in 1985 and is headquartered in Tacoma, Washington.

TBI Stock Price History

TBI Stock News Headlines

JetBlue TrueBlue
Trending Stocks Sent To You In Real Time
Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar!
the most reliable asset on earth is making a comeback
Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.
TrueBlue, Inc. (NYSE:TBI) Q4 2023 Earnings Call Transcript
Trueblue (TBI) Poised for Growth as Sector Recovers: Buy Rating Affirmed
Is TrueBlue, Inc. (NYSE:TBI) Trading At A 34% Discount?
Q4 2023 TrueBlue Inc Earnings Call
TrueBlue: Q4 Earnings Insights
TrueBlue: Q4 Earnings Snapshot
TrueBlue Reports Fourth Quarter and Full-Year 2023 Results
TrueBlue earnings preview: what Wall Street is expecting
TrueBlue Inc
Richard Pzena Increases Stake in TrueBlue Inc
See More Headlines
Receive TBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TrueBlue and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/21/2024
Today
3/28/2024
Next Earnings (Estimated)
4/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Help supply services
Sub-Industry
Human Resource & Employment Services
CUSIP
89785X10
Employees
5,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$19.00
High Stock Price Target
$20.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+52.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-14,170,000.00
Pretax Margin
-1.08%

Debt

Sales & Book Value

Annual Sales
$1.91 billion
Cash Flow
$1.46 per share
Book Value
$14.70 per share

Miscellaneous

Free Float
30,132,000
Market Cap
$391.12 million
Optionable
Optionable
Beta
1.48
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Ms. Taryn R. OwenMs. Taryn R. Owen (Age 45)
    CEO, President & Director
    Comp: $1.49M
  • Mr. Carl R. Schweihs (Age 38)
    Chief Financial Officer
    Comp: $1.1M
  • Mr. Garrett R. Ferencz (Age 46)
    Executive VP, General Counsel, Chief Ethics & Compliance Officer, Chief Legal Officer and Secretary
    Comp: $829.56k
  • Mr. Richard B. Christensen (Age 47)
    Senior VP, Chief Accounting Officer & Treasurer
  • Mr. Jeff Dirks
    Chief Technology & Information Officer
  • Ms. Caroline Sabetti
    Chief Marketing & Communications Officer
  • Mr. Greg Netolicky
    Chief People Officer
  • Mr. Anthony Brew
    Chief Diversity Officer
  • Mr. Richard P. Betori
    President of PeopleScout
  • Ms. Kristy Willis
    President of PeopleReady

TBI Stock Analysis - Frequently Asked Questions

Should I buy or sell TrueBlue stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TBI shares.
View TBI analyst ratings
or view top-rated stocks.

What is TrueBlue's stock price target for 2024?

1 Wall Street analysts have issued 12-month target prices for TrueBlue's stock. Their TBI share price targets range from $18.00 to $20.00. On average, they anticipate the company's share price to reach $19.00 in the next year. This suggests a possible upside of 50.8% from the stock's current price.
View analysts price targets for TBI
or view top-rated stocks among Wall Street analysts.

How have TBI shares performed in 2024?

TrueBlue's stock was trading at $15.34 at the beginning of 2024. Since then, TBI shares have decreased by 17.9% and is now trading at $12.60.
View the best growth stocks for 2024 here
.

Are investors shorting TrueBlue?

TrueBlue saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 1,640,000 shares, a decrease of 17.6% from the February 29th total of 1,990,000 shares. Based on an average daily volume of 439,000 shares, the short-interest ratio is presently 3.7 days. Approximately 5.5% of the shares of the company are sold short.
View TrueBlue's Short Interest
.

When is TrueBlue's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 22nd 2024.
View our TBI earnings forecast
.

How were TrueBlue's earnings last quarter?

TrueBlue, Inc. (NYSE:TBI) released its earnings results on Wednesday, February, 21st. The business services provider reported $0.08 EPS for the quarter, topping the consensus estimate of ($0.15) by $0.23. The business services provider earned $492.17 million during the quarter, compared to analysts' expectations of $472.53 million. TrueBlue had a negative net margin of 0.74% and a positive trailing twelve-month return on equity of 2.39%. The company's revenue was down 11.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.43 earnings per share.

What ETF holds TrueBlue's stock?

First Trust Dow Jones Select Microcap Index Fund holds 83,212 shares of TBI stock, representing 0.79% of its portfolio.

What guidance has TrueBlue issued on next quarter's earnings?

TrueBlue updated its first quarter 2024 earnings guidance on Wednesday, February, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $392.0 million-$417.0 million, compared to the consensus revenue estimate of $425.3 million.

What is Patrick Beharelle's approval rating as TrueBlue's CEO?

34 employees have rated TrueBlue Chief Executive Officer Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among the company's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of TrueBlue own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

Who are TrueBlue's major shareholders?

TrueBlue's stock is owned by many different institutional and retail investors. Top institutional shareholders include Pzena Investment Management LLC (9.93%), Vanguard Group Inc. (8.32%), Vanguard Group Inc. (8.25%), Dimensional Fund Advisors LP (6.58%), Charles Schwab Investment Management Inc. (2.88%) and Hotchkis & Wiley Capital Management LLC (2.60%). Insiders that own company stock include A Patrick Beharelle, Carl Schweihs, Derrek Lane Gafford, Garrett Ferencz, Kim Harris Jones, Kristi A Savacool, Kristy A Fitzsimmons-Willis, Richard Christensen, Richard P Betori, Robert C Kreidler, Steven C Cooper, Taryn R Owen and William C Goings.
View institutional ownership trends
.

How do I buy shares of TrueBlue?

Shares of TBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:TBI) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners